The Tumor-Associated Variant RAD51 G151D Induces a Hyper-Recombination Phenotype

• Carolyn G. Marsden,

  Affiliation Department of Microbiology and Molecular Genetics, The Markey Center for Molecular Genetics, University of Vermont, Burlington, Vermont, United States of America

  ⨯
• Ryan B. Jensen,

  Affiliation Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Jennifer Zagelbaum,

  Affiliation Department of Department of Biochemistry and Molecular Pharmacology, NYU School of Medicine, New York, New York, United States of America

  ⨯
• Eli Rothenberg,

  Affiliation Department of Department of Biochemistry and Molecular Pharmacology, NYU School of Medicine, New York, New York, United States of America

  ⨯
• Scott W. Morrical,

  Affiliations Department of Microbiology and Molecular Genetics, The Markey Center for Molecular Genetics, University of Vermont, Burlington, Vermont, United States of America, Department of Biochemistry, University of Vermont, Burlington, Vermont, United States of America

  ⨯
• Susan S. Wallace,

  Affiliation Department of Microbiology and Molecular Genetics, The Markey Center for Molecular Genetics, University of Vermont, Burlington, Vermont, United States of America

  ⨯
• Joann B. Sweasy

  * E-mail: joann.sweasy@yale.edu

  Affiliations Department of Microbiology and Molecular Genetics, The Markey Center for Molecular Genetics, University of Vermont, Burlington, Vermont, United States of America, Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯